FORT WORTH, Texas, Nov. 02, 2016 -- Tandy Leather Factory, Inc. (NASDAQ:TLF) announced today that it plans to release financial results for the three and nine months ended September 30, 2016 on Wednesday, November 9, 2016 before the market opens. A conference call will be conducted by senior management at 11:00 a.m. Eastern Time on November 9, 2016, and will be accessible to the public by calling 877-312-5524 or 253-237-1144. Callers should dial in approximately 5 minutes before the call begins.
A conference call replay will be available through 1:15 p.m. Eastern Time on November 14, 2016 and can be accessed by calling 855-859-2056 or 404-537-3406. For both, reference conference ID number 13624610.
This call is being webcast and can be accessed at the company’s web site at www.tandyleather.com.
Tandy Leather Factory, Inc., (http://www.tandyleather.com), headquartered in Fort Worth, Texas, is a specialty retailer and wholesale distributor of a broad product line including leather, leatherworking tools, buckles and adornments for belts, leather dyes and finishes, saddle and tack hardware, and do-it-yourself kits. The Company distributes its products through its 27 Leather Factory stores, located in 18 states and 3 Canadian provinces, 81 Tandy Leather retail stores, located in 36 states and 6 Canadian provinces, and four combination wholesale/retail stores located in the United Kingdom, Australia, and Spain. Its common stock trades on the Nasdaq with the symbol "TLF". To be included on Tandy Leather Factory’s email distribution list, go to http://www.b2i.us/irpass.asp?BzID=1625&to=ea&s=0.
This news release may contain statements regarding future events, occurrences, circumstances, activities, performance, outcomes and results that are considered “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. Actual results and events may differ from those projected as a result of certain risks and uncertainties. These risks and uncertainties include but are not limited to: changes in general economic conditions, negative trends in general consumer-spending levels, failure to realize the anticipated benefits of opening retail stores; availability of hides and leathers and resultant price fluctuations; change in customer preferences for our product, and other factors disclosed in our filings with the Securities and Exchange Commission. These forward-looking statements are made only as of the date hereof, and except as required by law, we do not intend to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact: Shannon L. Greene, Tandy Leather Factory, Inc. (817) 872-3200 or shannon,[email protected] Mark Gilbert, Magellan Fin, LLC (317) 867-2839 or [email protected]


ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



